I agree I think it's Kevetrin... According to t
Post# of 72440
According to the trials chart from the Biotech conf. it appears B-OM is a little over 1/3 done or approx. 20 patients. We need I think 36 before we get a reading on the trial. So we are probably 6 months away unless we get a few more sites up and running.
You are correct. there is so much sheet happening it's hard to keep track of.
I want to see who the New BOD member is gonna be....We should know soon.....very soon..